| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $17.6M | +53.1% |
| SG&A Expense | $13.4M | +9.3% |
| Operating Income | -$31.1M | -30.4% |
| Income Tax | $0 | — |
| Net Income | -$30.9M | -30.0% |
| EPS (Basic) | -$22.56 | -4412.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.7M | -67.8% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $7.5M | -64.9% |
| Total Assets | $10.7M | -57.5% |
| Current Liabilities | $3.3M | +15.8% |
| Stockholders' Equity | $7.4M | -66.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.7M | -39.1% |
| Investing Cash Flow | -$71K | -172.9% |
| Financing Cash Flow | $10.6M | — |